Protocol No
CVC-BMS-DISCOVER-HCM
Staff Member
Abhinav Sharma
Phase
N/A
Summary
This project is being done to evaluate the safety of mavacamten in patients with symptomatic oHCM in the real-world setting. The registry also provides a real-world understanding of the current oHCM patient population, treatment patterns, and clinically relevant outcomes for patients with symptomatic oHCM in the United States.
Objective
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov